02762nam 2200865z- 450 991055761550332120220321(CKB)5400000000045247(oapen)https://directory.doabooks.org/handle/20.500.12854/79585(oapen)doab79585(EXLCZ)99540000000004524720202203d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierAdvances in the Treatment of Renal Cell CarcinomaBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (221 p.)3-0365-2935-7 3-0365-2934-9 This Special Issue of Cancers focuses on new advances in the treatment of renal cell carcinoma, both surgical and pharmacological (and combinations of these), and novel approaches to tackle treatment resistance and improve our understanding of this phenomenon.Medicinebicsscartesunate (ART)autophagybiomarkerbiomarkersccRCCchloroquineclear cell renal cell carcinomacysteine cathepsin inhibitorscysteine cathepsinsevolutionevolutionary trajectoryferroptosisgenomic signaturegrowth inhibitionhydroxychloroquineimmune checkpoint inhibitorsimmune-based combination therapiesimmunotherapyindividualizationkidney cancerlysosomemetastaticmetastatic renal cell carcinomamRCCnetwork meta-analysisPD-L1predictiveRCCreactive oxygen species (ROS)renal cancerrenal cell cancerrenal cell carcinomarenal cell carcinoma (RCC)ROC-325second line therapysoluble factorssunitib resistanceTKIsTraditional Chinese Medicine (TCM)transcriptomic analysistreatmenttyrosine kinase inhibitorsMedicineReynolds Pauledt328165Stewart Grant DedtReynolds PaulothStewart Grant DothBOOK9910557615503321Advances in the Treatment of Renal Cell Carcinoma3022244UNINA